A new Study Raises Doubts About Antidepressant Use

A new study suggests that the majority of patients with depression may not benefit from taking antidepressant drugs.

Researchers from the University of Hull reviewed data from a number of trials involving the drugs Prozac (fluoxetine), Seroxat (paroxetine), Effexor (venlafaxine) and Serzone (nefazodone).

They concluded that the drugs may only be of benefit in patients with very severe depression.

However, the drugs' manufacturers have downplayed the findings, pointing out that other reports have shown them to be effective.

Prozac manufacturer Eli Lilly issued a statement saying: 'Extensive scientific and medical experience has demonstrated that Prozac is an effective antidepressant.

'Since its discovery in 1972, fluoxetine has become one of the world's most-studied medicines. More than 40 million people suffering from depression have been treated with fluoxetine in over 100 countries around the world.'

Experts have also cautioned that patients on antidepressants should not stop taking their medication in light of the latest research.

Marjorie Wallace, chief executive of the mental health charity Sane, said: 'These results are focused on clinical effectiveness rather than health risks.

'It is important that people should not stop taking the antidepressants immediately, as doing so could lead to severe rebound depression.'

source